Advanced Probiotic Combination to Shape a Beneficial Microbiome for Wellbeing
Ultra Flora MetaControl have been shown to or may:
- Provides metabolic benefits including reduced Body Mass Index (BMI), reduction in total cholesterol and Low Density Lipoprotein (LDL): Research has established a potential correlation between body weight and the microbiome. DNA analysis has shown that obese subjects may have a different microbiome composition to lean subjects. Gut bacterial composition is able to influence how energy is stored as well as influence glycaemic control and satiety hormones. Specific probiotics can be a useful adjunct to dietary programs to control weight, metabolic markers and body composition.
- Improves weight management including total and abdominal fat mass, waist circumference and reduced energy intake: Bifidobacterium lactis B-420™ has a growing body of human and animal research including a 2016 clinical trial. A 6 month study of 225 non–dieting, overweight people (mainly women aged 40+) took 10 billion B-420™ daily (with or without dietary fibre) or placebo. Both B-420™ groups showed significant improvements in fat mass, abdominal fat, waist circumference and lean muscle mass as well as an overall reduction in calorie consumption.
- Cardiometabolic markers can also be influenced by probiotics. A 2016 study on 51 adults with metabolic syndrome showed that Bifidobacterium animalis ssp lactis (HN019) reduced BMI, total cholesterol (TC) and Low density lipoprotein (LDL).The proposed mechanism is associated with prevention of cholesterol absorption by the intestinal tract into the blood stream, by aiding the assimilation of cholesterol during bacterial multiplication and cholesterol binding and to improve liver metabolism through increased Short Chain Fatty Acid (SCFA) production inhibiting HMG Co-A reductase. Mechanistically it has been shown to reduce proinflammatory cytokines TNF-α and IL-6, which are associated with the development of obesity.
Adults: Take 1 capsule daily.
Store at 2°C to 8°C (Refrigerate. Do not freeze.)
| Each capsule contains: | |
| 24 billion live probiotic organisms: | |
| Bifidobacterium animalis ssp lactis (HN019™) | 14 billion CFU (organisms) |
| Bifidobacterium animalis ssp lactis (B-420™) | 10 billion CFU (organisms) |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, soy protein and salt. Free from artificial colours, flavours and preservatives.
Excipients: Dibasic potassium phosphate, Disodium edetate, Gellan gum, Glucose, Hypromellose, Magnesium stearate, Microcrystalline cellulose, Monobasic potassium phosphate, Polysorbate 80, Potable water, Potassium acetate, Silicon dioxide and Sucrose.
As a precaution: Safety has not been conclusively established during pregnancy. Practitioner discretion is advised when prescribing for use in pregnancy due to the following cautions:
Pre-eclampsia: A meta-analysis of four clinical trials shows that taking probiotics during pregnancy increases the relative risk of pre-eclampsia.
The specific effects of Bifidobacterium animalis ssp lactis (B-420™) are unclear from this analysis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics on 1800 777 648 (Australia) or 0508 227 744 (New Zealand).
Advanced Probiotic Combination to Shape a Beneficial Microbiome for Wellbeing
Ultra Flora MetaControl have been shown to or may:
- Provides metabolic benefits including reduced Body Mass Index (BMI), reduction in total cholesterol and Low Density Lipoprotein (LDL): Research has established a potential correlation between body weight and the microbiome. DNA analysis has shown that obese subjects may have a different microbiome composition to lean subjects. Gut bacterial composition is able to influence how energy is stored as well as influence glycaemic control and satiety hormones. Specific probiotics can be a useful adjunct to dietary programs to control weight, metabolic markers and body composition.
- Improves weight management including total and abdominal fat mass, waist circumference and reduced energy intake: Bifidobacterium lactis B-420™ has a growing body of human and animal research including a 2016 clinical trial. A 6 month study of 225 non–dieting, overweight people (mainly women aged 40+) took 10 billion B-420™ daily (with or without dietary fibre) or placebo. Both B-420™ groups showed significant improvements in fat mass, abdominal fat, waist circumference and lean muscle mass as well as an overall reduction in calorie consumption.
- Cardiometabolic markers can also be influenced by probiotics. A 2016 study on 51 adults with metabolic syndrome showed that Bifidobacterium animalis ssp lactis (HN019) reduced BMI, total cholesterol (TC) and Low density lipoprotein (LDL).The proposed mechanism is associated with prevention of cholesterol absorption by the intestinal tract into the blood stream, by aiding the assimilation of cholesterol during bacterial multiplication and cholesterol binding and to improve liver metabolism through increased Short Chain Fatty Acid (SCFA) production inhibiting HMG Co-A reductase. Mechanistically it has been shown to reduce proinflammatory cytokines TNF-α and IL-6, which are associated with the development of obesity.
Adults: Take 1 capsule daily.
Store at 2°C to 8°C (Refrigerate. Do not freeze.)
| Each capsule contains: | |
| 24 billion live probiotic organisms: | |
| Bifidobacterium animalis ssp lactis (HN019™) | 14 billion CFU (organisms) |
| Bifidobacterium animalis ssp lactis (B-420™) | 10 billion CFU (organisms) |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, soy protein and salt. Free from artificial colours, flavours and preservatives.
Excipients: Dibasic potassium phosphate, Disodium edetate, Gellan gum, Glucose, Hypromellose, Magnesium stearate, Microcrystalline cellulose, Monobasic potassium phosphate, Polysorbate 80, Potable water, Potassium acetate, Silicon dioxide and Sucrose.
As a precaution: Safety has not been conclusively established during pregnancy. Practitioner discretion is advised when prescribing for use in pregnancy due to the following cautions:
Pre-eclampsia: A meta-analysis of four clinical trials shows that taking probiotics during pregnancy increases the relative risk of pre-eclampsia.
The specific effects of Bifidobacterium animalis ssp lactis (B-420™) are unclear from this analysis.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics on 1800 777 648 (Australia) or 0508 227 744 (New Zealand).